Fungi, immunosenescence and cancer
- PMID: 39788169
- DOI: 10.1016/j.semcancer.2025.01.002
Fungi, immunosenescence and cancer
Abstract
Fungal microbes are a small but immunoreactive component of the human microbiome, which may influence cancer development, progression and therapeutic response. Immunosenescence is a process of immune dysfunction that occurs with aging, including lymphoid organ remodeling, contributing to alterations in the immune system in the elderly, which plays a critical role in many aspects of cancer. There is evidence for the interactions between fungi and immunosenescence in potentially regulating cancer progression and remodeling the tumor microenvironment (TME). In this review, we summarize potential roles of commensal and pathogenic fungi in modulating cancer-associated processes and provide more-detailed discussions on the mechanisms of which fungi affect tumor biology, including local and distant regulation of the TME, modulating antitumor immune responses and interactions with neighboring bacterial commensals. We also delineate the features of immunosenescence and its influence on cancer development and treatment, and highlight the interactions between fungi and immunosenescence in cancer. We discuss the prospects and challenges for harnessing fungi and immunosenescence in cancer diagnosis and/or treatment. Considering the limited understanding and techniques in conducting such research, we also provide our view on how to overcome challenges faced by the exploration of fungi, immunosenescence and their interactions on tumor biology.
Keywords: Cancer; Fungi; Immunosenescence; Treatment; Tumor microenvironment.
Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Gut microbiota and immunosenescence in cancer.Semin Cancer Biol. 2024 Sep;104-105:32-45. doi: 10.1016/j.semcancer.2024.07.004. Epub 2024 Aug 8. Semin Cancer Biol. 2024. PMID: 39127266 Review.
-
Cancer-associated fungi: An emerging powerful player in cancer immunotherapy.Biochim Biophys Acta Rev Cancer. 2025 Apr;1880(2):189287. doi: 10.1016/j.bbcan.2025.189287. Epub 2025 Feb 17. Biochim Biophys Acta Rev Cancer. 2025. PMID: 39971202 Review.
-
Fungi and cancer.Gut. 2023 Jul;72(7):1410-1425. doi: 10.1136/gutjnl-2022-327952. Epub 2023 May 5. Gut. 2023. PMID: 37147013 Review.
-
Mechanisms and strategies of immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions.Semin Cancer Biol. 2025 Feb;109:44-66. doi: 10.1016/j.semcancer.2025.01.001. Epub 2025 Jan 9. Semin Cancer Biol. 2025. PMID: 39793777 Review.
-
Remodeling of tumor microenvironment by cellular senescence and immunosenescence in cervical cancer.Semin Cancer Biol. 2025 Jan;108:17-32. doi: 10.1016/j.semcancer.2024.11.002. Epub 2024 Nov 23. Semin Cancer Biol. 2025. PMID: 39586414 Review.
Cited by
-
Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategies.Mol Cancer. 2025 Jul 8;24(1):193. doi: 10.1186/s12943-025-02397-5. Mol Cancer. 2025. PMID: 40629335 Free PMC article. Review.
-
Immunosenescence: signaling pathways, diseases and therapeutic targets.Signal Transduct Target Ther. 2025 Aug 6;10(1):250. doi: 10.1038/s41392-025-02371-z. Signal Transduct Target Ther. 2025. PMID: 40769978 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical